Suppr超能文献

[H2受体阻滞剂治疗十二指肠溃疡。雷尼替丁2×150毫克与西咪替丁2×400毫克的对比]

[Therapy of duodenal ulcer with H2-blockers. 2 x 150 mg ranitidine versus 2 x 400 mg cimetidine].

作者信息

Hüttemann W

出版信息

Fortschr Med. 1983 Jan 27;101(4):139-41.

PMID:6131857
Abstract

60 out-patients with acute duodenal ulcers were treated in an open randomized trial with 2 x 150 mg ranitidine or 2 x 400 mg cimetidine, respectively. At endoscopy after 12 and 24 days there was evidence of complete healing in 63% and 93% in the ranitidine- and 57% and 83% in the cimetidine-treated group. Although the symptoms in both groups improved during treatment with H2-blockers, there was a more rapid relief in pain in the ranitidine-group (p less than 0.01). The more favorable results with ranitidine, 150 mg twice daily, warrant further clinical evaluation.

摘要

60例急性十二指肠溃疡门诊患者参与了一项开放随机试验,分别接受2×150毫克雷尼替丁或2×400毫克西咪替丁治疗。在12天和24天后的内镜检查中,雷尼替丁治疗组的溃疡完全愈合率分别为63%和93%,西咪替丁治疗组分别为57%和83%。尽管两组患者在使用H2阻滞剂治疗期间症状均有所改善,但雷尼替丁组的疼痛缓解更为迅速(p<0.01)。每日两次服用150毫克雷尼替丁的更佳疗效值得进一步临床评估。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验